Funding
Growth · Biotech

S-Curve Partners backs CND Life Sciences growth financing

CND Life Sciences announced growth financing in August, with S-Curve Partners among its backers.

Updated Oct 16, 2026By RoundOS Funding desk

The amount was not disclosed. The company develops biomarker-based diagnostic tests for neurodegenerative diseases.

Funding history

Growth · This roundUndisclosed

Sources

  1. CND Life Sciencesprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related